Concepedia

Alan P. Lyss

AP

50

Publications

3.9K

Citations

30

H-Index

1975

Active since

Affiliations

Missouri Baptist Medical Center(Current)

Heartland Cancer Research

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Alan P. Lyss is an author at Missouri Baptist Medical Center specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1975–2024

50

Publications

50

Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer

Panos Fidias, Shaker R. Dakhil, Alan P. Lyss et al. · Journal of Clinical Oncology · 2008 · 421 citations · Full text

Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

Joanne L. Blum, Patrick J. Flynn, Greg Yothers et al. · Journal of Clinical Oncology · 2017 · 280 citations

Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.

Douglas B. Cines, Alan P. Lyss, Miriam J. Reeber et al. · Journal of Clinical Investigation · 1984 · 250 citations · Full text

, , +16

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

Erica L. Mayer, Amylou C. Dueck, Miguel Martín et al. · The Lancet Oncology · 2021 · 250 citations

, , +9

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

Russell K. Portenoy, Richard Payne, Paul Coluzzi et al. · Pain · 1999 · 240 citations

Rows per page

1–5 of 50